Pulse Biosciences Financials - Benzinga

Pulse Biosciences Inc

PLSENASDAQ

Trade with Public

Trade with Public

$51.68

-0.15-0.3%

Últ. Act.: Sep 25, 9:13 AM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Comparar Opciones Informe de acciones

Pulse Biosciences Financials

Pulse Biosciences (PLSE) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Pulse Biosciences Q2 EPS $(0.36), Inline, Sales $434.000K Miss $533.333K Estimate

Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.36) per share which met the analyst consensus estimate. This is a 28.57 percent decrease over losses of $(0.28) per share from the same period last year.

Benzinga Newsdesk

Earnings Scheduled For May 4, 2026

Benzinga Insights

PRO
Pulse Biosciences Q1 EPS $(0.27) Beats $(0.32) Estimate, Sales $401.000K Beat $400.000K Estimate

Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.32) by 12.9 percent. This is a 8 percent decrease over losses of $(0.25) per share from the

Benzinga Newsdesk

Pulse Biosciences Q4 Earnings Report: What Investors Need to Know

Benzinga Insights

PRO
Pulse Biosciences Q4 EPS $(0.26) Beats $(0.31) Estimate, Sales $264.000K Beat $250.000K Estimate

Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.31) by 16.13 percent. This is a 16.13 percent increase over losses of $(0.31) per share from

Benzinga Newsdesk

Earnings Scheduled For February 19, 2026

Benzinga Insights

© 2026 Benzinga | All Rights Reserved